CYP 4.00% 26.0¢ cynata therapeutics limited

Ann: Investor Presentation, page-594

  1. 3,936 Posts.
    lightbulb Created with Sketch. 287
    I will set you a challenge then to declare.

    "Everything I am researching says beware of tumorous cell splitting mutations?"

    That is my statement so I now want you to declare that there is..... no possibility of tumorous mutations with iPSC therapy?

    Declare it with proof of actual therapy in humans and we can move on.

    I get it that we all see stem cells as the golden ticket.

    Some are just a bit more greedy and the FDA need to go with nature before artificial when something is new to approval.
    Last edited by gavint66: 25/06/24
 
watchlist Created with Sketch. Add CYP (ASX) to my watchlist
(20min delay)
Last
26.0¢
Change
0.010(4.00%)
Mkt cap ! $46.70M
Open High Low Value Volume
24.5¢ 26.5¢ 24.5¢ $22.36K 88.15K

Buyers (Bids)

No. Vol. Price($)
1 30000 25.0¢
 

Sellers (Offers)

Price($) Vol. No.
29.0¢ 4125 2
View Market Depth
Last trade - 15.55pm 10/07/2024 (20 minute delay) ?
CYP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.